Unaudited Financial results for the quarter and twelve months ended November 30, 2010 (Rupees in Lakhs)

Sr.No Particulars 3 months ended Nov 30, 2010 (Unaudited)

1 Net Sales/Income from Operations a Gross Sales Less : Excise Duty Net Sales b Other Operating Income Expenditure a (Increase)/decrease in stock in trade & work-in-progress b Consumption of raw materials c Purchase of Traded Goods d Employees Cost e Depreciation f Other Expenditure g Total Expenditure Profit from Operations before Other Income and Interest (1-2) Other Income Profit before Interest (3+4) Interest Profit before Tax Tax Expenses (including current tax, deferred taxation, fringe benefit tax and prior period adjustments for the period) Net Profit for the period Paid- up Equity Share Capital (Face value of the share Rs. 10). Reserves excluding revaluation reserves (as per last audited balance sheet) Basic and diluted Earnings per share for the periods, for the year to date (not annualized) and for the previous year Rs. Public shareholding Number of Shares Percentage of Shareholding Promoters and promoter group shareholding a Pledged/ Encumbered Number of Shares Percentage of Shares (as a % of the total shareholding of promoter and promoter group) Percentage of Shares (as a % of the total share capital of the company) Non - encumbered Number of Shares Percentage of Shares (as a % of the total shareholding of promoter and promoter group) Percentage of Shares (as a % of the total share capital of the company) 270,38 1,85 268,53 8,93 34,97 11,03 121,60 28,74 3,16 41,68 241,18 36,28 2,05 38,33 38,33 12,80

12 months ended Nov 30, 2010 (Unaudited)

946,71 6,05 940,66 26,19 31,22 40,85 533,48 100,22 9,96 143,47 859,20 107,65 6,02 113,67 1 113,66 38,36

Nov 30, 2009 (Unaudited)

203,60 1,37 202,23 10,70 (2,06) 11,30 122,23 17,07 2,70 27,95 179,19 33,74 99 34,73 7 34,66 11,01

Nov 30, 2009 (Audited)

766,64 5,72 760,92 23,41 (10,78) 46,12 468,82 62,37 9,01 97,08 672,62 111,71 5,87 117,58 20 117,38 39,87

3 4 5 6 7 8

9 10 11 12

25,53 13,68

23,65 13,68

75,30 13,68

77,51 13,68 257,88

18.67

17.29

55.06

56.68

13

42,47,056 31.06%

42,47,056 31.06%

42,47,056 31.06%

42,47,056 31.06%

14

94,28,184 100.00%

94,28,184 100.00%

94,28,184 100.00%

94,28,184 100.00%

68.94%

68.94%

68.94%

68.94%

Notes : 1. The results for the quarter and 12 months ended Nov 30, 2010 have been reviewed by the Audit Committee, approved by the Board of Directors and subjected to a Limited Review by the auditors of the Company, in compliance with Clause 41 of the Listing Agreement with Bombay Stock Exchange Limited.

2.

Unaudited statement of assets and liabilities as at Nov 30, 2010 Particulars As at Nov 30, 2010
(Unaudited) Rs in Lakhs Shareholders Funds (a) Capital (b) Reserves and Surplus

As at Nov 30, 2009

(Audited) Rs in Lakhs

13,68 333,18 346,86 24 347,10

13,68 257,88 271,56 2,20 273,76

Deferred Tax Liability (Net) Total

Fixed Assets Current Assets, Loans and Advances (a) Inventories (b) Sundry Debtors (c) Cash and Bank Balances (d) Other Current Assets (e) Loans and Advances Less : Current Liabilities and Provisions (a) Liabilities (b) Provisions

50,16

49,15

70,67 79,39 212,55 97 25,64 389,22 66,09 26,19 92,28 296,94 347,10

102,38 44,40 175,61 43 10,95 333,77 57,90 51,26 109,16 224,61 273,76

Net Current Assets Total

3. 4.

5.

6. 7. 8.

The company continues to make strategic investments for expanding its field force to improve market coverage and enhanced promotional efforts to increase market share. The Board of Directors of the Company has, at its meeting held on November 24, 2010, unanimously approved the draft Scheme of Amalgamation (Scheme) of Solvay Pharma India Limited into Abbott India Limited under Sections 391 to 394 of the Companies Act, 1956, subject to necessary statutory approvals. The swap ratio for the merger is 2:3 i.e. every two shares of Solvay Pharma India Limited will entitle their holder to three shares of Abbott India Limited. The Company has changed its financial year from December 1 - November 30 to January 1 - December 31 from current year onwards. Accordingly, the current financial year is for 13 months from 1 December 2009 to 31 December 2010. In terms of Clause 41 of the Listing Agreement, the results for quarter ended November 30, 2010 are being published. Also, the Company will be publishing the results for the period from December 1, 2009 to December 31, 2010. The Company operates in one reportable business segment i.e. Pharmaceuticals and one reportable geographical segment i.e. Within India. There were no Investor Complaints pending at the beginning of the quarter. The Company received 5 complaints from the investors and all the complaints were resolved and disposed off during the quarter. There were no complaints lying unresolved at the end of the quarter. Figures for the prior year / period have been regrouped and/or reclassified wherever considered necessary.

Abbott India Limited

Mumbai : Dec 21, 2010

Vivek Mohan Managing Director